Literature DB >> 21546112

The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes.

Beatriz Orcajo1, Francisco Muruzabal2, María Concepción Isasmendi3, Nerea Gutierrez3, Mikel Sánchez4, Gorka Orive2, Eduardo Anitua2.   

Abstract

A 71 year old person with diabetes with a severe mal perforant ulcer in the right foot was treated twice with autologous plasma-rich in growth factors (PRGF) obtained from her own blood. After PRGF treatment the severe mal perforant ulcer completely healed in 10 weeks.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21546112     DOI： 10.1016/j.diabres.2011.04.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  4 in total

1.  Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing.

Authors:  F R Henshaw; P Boughton; L Lo; S V McLennan; S M Twigg
Journal:  J Diabetes Res       Date:  2015-02-18       Impact factor: 4.011

2.  The Antimicrobial Peptide Human Beta-Defensin-3 Is Induced by Platelet-Released Growth Factors in Primary Keratinocytes.

Authors:  Andreas Bayer; Justus Lammel; Mersedeh Tohidnezhad; Sebastian Lippross; Peter Behrendt; Tim Klüter; Thomas Pufe; Jochen Cremer; Holger Jahr; Franziska Rademacher; Regine Gläser; Jürgen Harder
Journal:  Mediators Inflamm       Date:  2017-07-25       Impact factor: 4.711

3.  Autologous Platelet Rich Plasma (PRGF) Preserves Genomic Stability of Gingival Fibroblasts and Alveolar Osteoblasts after Long-Term Cell Culture.

Authors:  Eduardo Anitua; María de la Fuente; María Troya; Mar Zalduendo; Mohammad Hamdan Alkhraisat
Journal:  Dent J (Basel)       Date:  2022-09-14

4.  Recalcitrant cutaneous ulcer of comorbid patient treated with platelet rich plasma: a case report.

Authors:  Dai Hyun Kim; Jong Yeob Kim; Soo Hong Seo; Hyo Hyun Ahn; Young Chul Kye; Jae Eun Choi
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.